Virtu Financial’s Clearside Biomedical CLSD Stock Holding History

Virtu Financial’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-900	Closed	-$13K	–	1444
2024 Q4	$13K	Buy	+900	New	+$14.8K	﹤0.01%	1356
2024 Q1	–	Sell	-1,168	Closed	-$20K	–	1495
2023 Q4	$20K	Buy	+1,168	New	+$16.7K	﹤0.01%	1319
2023 Q3	–	Sell	-2,256	Closed	-$38K	–	1382
2023 Q2	$38K	Buy	+2,256	New	+$38.8K	﹤0.01%	1172
2022 Q1	–	Sell	-972	Closed	-$40K	–	1561
2021 Q4	$40K	Buy	+972	New	+$63K	﹤0.01%	1387
2020 Q3	–	Sell	-886	Closed	-$25K	–	1122
2020 Q2	$25K	Buy	+886	New	+$26.1K	﹤0.01%	1110
2019 Q4	$153K	Buy	3,510 +2,749	+361%	+$57.8K	0.01%	1000
2019 Q3	$7K	Buy	+761	New	+$10.9K	﹤0.01%	1363
2019 Q2	–	Sell	-4,602	Closed	-$95K	–	1496
2019 Q1	$95K	Buy	4,602 +1,048	+29%	+$20.8K	0.01%	1136
2018 Q4	$57K	Buy	+3,554	New	+$167K	﹤0.01%	1248
2018 Q2	–	Sell	-890	Closed	-$143K	–	2026
2018 Q1	$143K	Buy	+890	New	+$108K	0.01%	1480

Other funds holding CLSD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's CLSD Position: Q1 2025 in Review

Virtu Financial sold out of Clearside Biomedical (CLSD) in Q1 2025, closing a stake of 900 shares — an estimated $13K sold.

Virtu Financial first reported a position in CLSD in Q1 2018 and held it in 10 quarters. The position peaked at $153K in Q4 2019. 43 funds tracked by Wall St. Rank hold CLSD as of Q1 2025.

Virtu Financial reported no remaining Clearside Biomedical position as of Q1 2025 after selling out during the quarter.
Virtu Financial sold 900 Clearside Biomedical shares in Q1 2025, an estimated $13K.
Virtu Financial first reported a position in Clearside Biomedical in Q1 2018 and held it in 10 quarters.
Virtu Financial's Clearside Biomedical position peaked at $153K in Q4 2019.
43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.